Name: Lineage Cell Therapeutics, Inc. (LCTX) Balance Sheet
Creator: FinSpry

Lineage Cell Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Lineage Cell Therapeutics, Inc. (LCTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	45.79	35.44	11.36	58.36	41.56	30.72	30.74
Short-Term Investments	2.02	0.05	46.52	2.62	8.98	0.00	0.00
Cash & Short-Term Investments	47.81	35.49	57.88	58.36	41.56	30.72	30.74
Accounts Receivable	0.64	0.75	0.30	50.84	0.00	23.94	3.72
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.55	2.20	1.83	0.54	2.36	0.00	0.00
Total Current Assets	51.00	38.44	60.00	111.55	44.00	57.52	36.36
Non-Current Assets
Property, Plant & Equipment (Net)	4.40	4.77	5.67	4.87	5.63	8.18	5.84
Goodwill	10.67	10.67	10.67	10.67	10.67	0.00	0.00
Intangible Assets	46.54	46.56	46.69	46.82	47.03	0.00	0.00
Other Non-Current Assets	0.61	0.58	0.63	0.54	0.52	0.60	0.00
Total Non-Current Assets	62.22	62.58	63.66	63.00	63.95	67.96	65.30
Total Assets	113.22	101.02	123.66	174.55	107.95	125.48	101.66
Current Liabilities
Accounts Payable	1.17	2.05	2.39	27.97	6.81	5.23	4.00
Short-Term Debt	1.15	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	4.26	1.10	6.22	22.09	3.67	0.00	0.00
Deferred Revenue	7.39	10.81	9.42	18.12	0.19	0.00	0.00
Other Current Liabilities	4.26	3.12	2.38	2.16	1.96	0.00	0.01
Total Current Liabilities	13.98	17.96	18.98	47.12	7.77	6.49	6.81
Non-Current Liabilities
Long-Term Debt	1.36	2.07	2.94	1.97	2.54	3.95	1.96
Deferred Tax Liabilities	0.27	0.27	2.08	2.08	2.08	0.00	0.00
Other Non-Current Liabilities	6.16	29.50	0.00	0.23	0.00	0.00	0.00
Total Non-Current Liabilities	22.23	21.04	32.75	36.73	5.05	7.74	2.60
Total Liabilities	36.21	39.00	51.73	83.65	12.82	14.23	9.41
Stockholders' Equity
Common Stock	484.72	451.34	440.28	434.53	393.94	0.00	0.00
Retained Earnings	-403.47	-384.86	-363.37	-342.31	-297.75	-273.42	-261.86
Accumulated Other Comprehensive Income	-2.88	-3.07	-3.57	-5.21	-3.67	-0.68	1.43
Minority Interest	-1.37	-1.40	-1.40	-1.32	-1.07	-1.71	-1.59
Shares Outstanding	220.42	174.99	170.09	169.48	0.00	0.00	0.00
Total Stockholders' Equity	77.01	63.42	71.94	90.90	95.13	111.25	92.25
Total Liabilities & Equity	113.22	101.02	123.66	174.55	107.95	125.48	101.66